Skip to main content

Aerobic Exercise Might Ease Pain for Women Who've Survived Ovarian Cancer

Medically reviewed by Drugs.com.

By Cara Murez HealthDay Reporter

WEDNESDAY, Aug. 9, 2023 -- Patients being treated for ovarian cancer often experience peripheral neuropathy, a side effect from their chemotherapy that can cause both pain and numbness for months, or even years.

Now, a new study suggests that six months of aerobic exercise may ease this unpleasant side effect.

"The results from this trial hold the potential to transform supportive care for ovarian cancer survivors by offering a new approach to managing CIPN [chemotherapy-induced peripheral neuropathy]," said senior study author Leah Ferrucci, an assistant professor of epidemiology at the Yale School of Public Health and a member of Yale Cancer Center.

"These findings provide compelling evidence that a structured, home-based aerobic exercise program can significantly improve CIPN in ovarian cancer survivors who have completed chemotherapy," Ferrucci said in a Yale news release.

The structured aerobic exercise intervention in the study had already been found to improve physical health-related quality of life. For this new research on patients with ovarian cancer who received chemotherapy, the investigators evaluated the impact of the exercise program and compared it to a control group of patients not in the exercise program.

Patients in the exercise intervention arm of the study had a reduction of 1.3 points in CIPN symptoms at the end of the six-month program. Those in the control group, who only received weekly health education phone calls, had a minor increase in CIPN symptoms of 0.4 points.

The positive effects of aerobic exercise were even stronger for participants who had CIPN symptoms when they enrolled in the trial. This subgroup experienced a 2-point reduction in CIPN severity.

The research, which was published Aug. 1 in the journal JAMA Network Open, was supported by the U.S. National Cancer Institute, the U.S. National Center for Advancing Translational Science, and the Yale Claude D. Pepper Older Americans Independence Center.

"Incorporating referrals to exercise intervention programs into standard oncology care could be a game-changer, reducing CIPN symptoms and enhancing the quality of life for patients with ovarian cancer," study first author Anlan Cao, a doctoral student at the Yale School of Public Health, said the release.

"While further studies are needed to replicate these promising results in patients with ovarian cancer and other cancer types, if aerobic exercise proves to be a reliable treatment for CIPN, it could offer a wide range of cancer survivors a better approach to manage neuropathy symptoms," Cao noted.

Sources

  • Yale Cancer Center/Smilow Cancer Hospital, news release, Aug. 7, 2023

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

Johnson & Johnson Will Pay $6.5 Billion to Settle Talc Ovarian Cancer Lawsuits

THURSDAY, May 2, 2024 -- Johnson & Johnson announced Wednesday that it would pay out more than $6.5 billion over the next 25 years to settle existing lawsuits claiming that...

AI May Bring a Better Blood Test for Ovarian Cancer

WEDNESDAY, April 10, 2024 -- Using AI to track fragments of tumor-associated DNA in the blood, scientists say they may be close to an accurate test for a silent killer: Ovarian...

Common PFAS Chemicals Linked to Cancers in Women

TUESDAY, Sept. 19, 2023 -- Harmful "forever" chemicals are widespread in the environment, and new research hints they pose a particular health risk to women. A new study suggests...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.